| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |